ANGLE plc
http://www.angleplc.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ANGLE plc
Minute Insight: Angle’s Parsortix Gets FDA Approval, Marking New Era For Liquid Biopsy
The FDA has approved Angle’s Parsortix circulating tumor cell cancer capturing system, which the company believes will be a paradigm shift for liquid biopsy in the US and heighten competition in the oncology diagnostics space.
Angle Outlines Strategy As It Nears Major Regulatory Announcements
With approvals looming over the next few months, Angle spoke to Medtech Insight to probe deeper about its presentation at the 2021 Jefferies Healthcare Conference.
Angle Is Ready To Capitalize On Promise Of Capture Cell Technology
Angle PLC has published half year interim results which indicate it will capitalize on a new liquid biopsy market.
Angle Will Reshape Liquid Diagnostics By Capturing Circulating Tumor Cells
Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis
Company Information
- Industry
- Biotechnology
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Axela Inc.